Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:ECOR NASDAQ:MOVE NASDAQ:POCI NASDAQ:SLNO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeECORelectroCore$7.27-1.6%$5.63$4.47▼$19.49$53.95M0.8107,481 shs43,201 shsMOVEMovano$0.68+9.7%$0.71$0.51▼$6.97$4.79M0.89213,826 shs322,683 shsPOCIPrecision Optics$4.79-0.5%$4.67$3.47▼$6.59$36.49M0.2516,176 shs7,294 shsSLNOSoleno Therapeutics$87.20-0.5%$79.81$41.50▼$90.32$4.39B-2.63856,334 shs1.19 million shs7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceECORelectroCore0.00%+5.67%+38.48%+20.76%+16.60%MOVEMovano0.00%-2.86%-11.69%-27.27%-88.94%POCIPrecision Optics0.00%-2.35%+4.70%+20.99%-20.25%SLNOSoleno Therapeutics0.00%+6.90%+9.85%+24.61%+79.13%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationECORelectroCore2.7815 of 5 stars3.54.00.00.00.62.50.6MOVEMovano2.694 of 5 stars3.54.00.00.01.90.80.6POCIPrecision OpticsN/AN/AN/AN/AN/AN/AN/AN/ASLNOSoleno Therapeutics4.2876 of 5 stars3.51.00.04.63.52.50.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceECORelectroCore 3.00Buy$25.50250.76% UpsideMOVEMovano 3.00Buy$30.004,311.76% UpsidePOCIPrecision Optics 0.00N/AN/AN/ASLNOSoleno Therapeutics 3.09Buy$108.7024.66% UpsideCurrent Analyst Ratings BreakdownLatest ECOR, POCI, SLNO, and MOVE Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/11/2025SLNOSoleno TherapeuticsRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingSet Price TargetOutperform ➝ Outperform$105.00 ➝ $121.006/23/2025SLNOSoleno TherapeuticsCowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy6/23/2025SLNOSoleno TherapeuticsTD CowenSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$110.005/8/2025SLNOSoleno TherapeuticsGuggenheimSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$81.00 ➝ $97.005/8/2025SLNOSoleno TherapeuticsRobert W. BairdSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOutperform ➝ Outperform$102.00 ➝ $105.004/24/2025SLNOSoleno TherapeuticsPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$93.00 ➝ $145.00(Data available from 7/20/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookECORelectroCore$25.18M2.14N/AN/A$1.13 per share6.43MOVEMovano$1.01M4.74N/AN/A$1.11 per share0.61POCIPrecision Optics$19.10M1.92N/AN/A$1.66 per share2.88SLNOSoleno TherapeuticsN/AN/AN/AN/A$5.68 per shareN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateECORelectroCore-$11.89M-$1.56N/AN/AN/A-46.24%-149.04%-61.24%8/6/2025 (Estimated)MOVEMovano-$23.73M-$4.07N/A∞N/AN/A-288.42%-181.30%8/13/2025 (Estimated)POCIPrecision Optics-$2.95M-$0.89N/A∞N/A-32.84%-54.03%-32.48%9/29/2025 (Estimated)SLNOSoleno Therapeutics-$175.85M-$4.62N/AN/AN/AN/A-77.52%-63.44%8/6/2025 (Estimated)Latest ECOR, POCI, SLNO, and MOVE EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/13/2025Q1 2025MOVEMovano-$0.70N/AN/AN/A$3.88 millionN/A8/6/2025Q2 2025ECORelectroCore-$0.32N/AN/AN/A$7.24 millionN/A8/6/2025Q2 2025SLNOSoleno Therapeutics-$0.85N/AN/AN/A$3.91 millionN/A5/15/2025Q3 2025POCIPrecision OpticsN/A-$0.30N/A-$0.30N/A$4.19 million5/7/2025Q1 2025ECORelectroCore-$0.56-$0.47+$0.09-$0.47$6.93 million$6.72 million5/7/2025Q1 2025SLNOSoleno Therapeutics-$1.14-$0.95+$0.19-$0.95N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthECORelectroCoreN/AN/AN/AN/AN/AMOVEMovanoN/AN/AN/AN/AN/APOCIPrecision OpticsN/AN/AN/AN/AN/ASLNOSoleno TherapeuticsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioECORelectroCoreN/A1.521.30MOVEMovanoN/A3.022.42POCIPrecision Optics0.111.991.26SLNOSoleno Therapeutics0.2119.6419.64Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipECORelectroCore26.74%MOVEMovano16.64%POCIPrecision Optics13.71%SLNOSoleno Therapeutics97.42%Insider OwnershipCompanyInsider OwnershipECORelectroCore19.70%MOVEMovano13.40%POCIPrecision Optics12.99%SLNOSoleno Therapeutics6.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableECORelectroCore507.42 million5.96 millionNot OptionableMOVEMovano307.04 million6.09 millionNot OptionablePOCIPrecision Optics807.67 million6.67 millionNot OptionableSLNOSoleno Therapeutics3050.39 million47.17 millionOptionableECOR, POCI, SLNO, and MOVE HeadlinesRecent News About These CompaniesBrokers Set Expectations for SLNO FY2025 Earnings5 hours ago | americanbankingnews.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Shares Purchased by Atle Fund Management ABJuly 19 at 9:11 AM | marketbeat.com11 Best Performing Mid Cap Stocks So Far In 2025July 18 at 12:36 PM | insidermonkey.comFY2025 EPS Estimates for SLNO Raised by Cantor FitzgeraldJuly 18 at 10:31 AM | marketbeat.comBank of New York Mellon Corp Buys 234,649 Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO)July 18 at 3:24 AM | marketbeat.comSoleno Therapeutics: Fairly Valued Despite M&A ExpectationsJuly 16, 2025 | seekingalpha.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Shares Sold by TimesSquare Capital Management LLCJuly 15, 2025 | marketbeat.comSoleno Therapeutics (NASDAQ:SLNO) Price Target Raised to $121.00 at Robert W. BairdJuly 14, 2025 | americanbankingnews.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) is Emerald Advisers LLC's 8th Largest PositionJuly 13, 2025 | marketbeat.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) is Emerald Mutual Fund Advisers Trust's 7th Largest PositionJuly 12, 2025 | marketbeat.comSoleno Therapeutics Shares Dip Following $200 Million Stock Offering PricingJuly 11, 2025 | msn.comSoleno Therapeutics (NASDAQ:SLNO) Stock Price Expected to Rise, Robert W. Baird Analyst SaysJuly 11, 2025 | marketbeat.comSoleno Therapeutics (NASDAQ:SLNO) Sees Unusually-High Trading Volume - Time to Buy?July 10, 2025 | marketbeat.comSoleno Therapeutics stock dips on proposed $200M offeringJuly 10, 2025 | msn.comSoleno Therapeutics Announces Pricing of $200 Million Public Offering of Common StockJuly 10, 2025 | globenewswire.comSoleno Therapeutics, Inc. Announces $200 Million Public Offering to Fund VYKAT XR Commercialization and R&D ActivitiesJuly 10, 2025 | quiverquant.comQSoleno Therapeutics Reports Preliminary Financial Results for Q2 2025, Anticipating $31-$33 Million in Revenue from VYKAT™ XRJuly 10, 2025 | quiverquant.comQSoleno Therapeutics Announces Proposed $200 Million Public Offering of Common StockJuly 10, 2025 | globenewswire.comSoleno Therapeutics Announces Preliminary Financial and Operational Results for the Second Quarter Ended June 30, 2025July 10, 2025 | globenewswire.comSoleno Therapeutics (NASDAQ:SLNO) Sets New 52-Week High - Time to Buy?July 9, 2025 | marketbeat.comSoleno Therapeutics, Inc. (NASDAQ:SLNO) Given Consensus Recommendation of "Buy" by BrokeragesJuly 9, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWhy BigBear.ai Could Rally 100% and Catch Palantir SoonBy Gabriel Osorio-Mazilli | June 30, 2025View Why BigBear.ai Could Rally 100% and Catch Palantir Soon3 Defense Leaders Set to Gain From Rising Military SpendBy Chris Markoch | July 5, 2025View 3 Defense Leaders Set to Gain From Rising Military SpendPalantir Gets Price Hike From Wedbush Amid High ValuationBy Chris Markoch | July 15, 2025View Palantir Gets Price Hike From Wedbush Amid High ValuationWhiplash for Investors: AeroVironment's Confusing Stock SignalsBy Jeffrey Neal Johnson | July 2, 2025View Whiplash for Investors: AeroVironment's Confusing Stock SignalsFull Steam Ahead: The Bullish Case for Carnival StockBy Jeffrey Neal Johnson | July 18, 2025View Full Steam Ahead: The Bullish Case for Carnival StockECOR, POCI, SLNO, and MOVE Company DescriptionselectroCore NASDAQ:ECOR$7.27 -0.12 (-1.62%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$7.32 +0.06 (+0.76%) As of 07/18/2025 04:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.Movano NASDAQ:MOVE$0.68 +0.06 (+9.68%) Closing price 07/18/2025 03:57 PM EasternExtended Trading$0.66 -0.02 (-3.38%) As of 07/18/2025 07:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Movano Inc. engages in developing a platform to deliver healthcare solutions at the intersection of medical and consumer devices. The company is involved in the development of Evie Ring, which is a wearable designed specifically for women that combines health and wellness metrics comprises resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, and menstrual symptom tracking, as well as activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking. It develops System-on-a-Chip (SoC) for blood pressure or continuous glucose monitoring (CGM) systems. The company was formerly known as Maestro Sensors Inc. and changed its name to Movano Inc. in August 2018. Movano Inc. was incorporated in 2018 and is based in Pleasanton, California.Precision Optics NASDAQ:POCI$4.78 -0.03 (-0.52%) Closing price 07/18/2025 03:57 PM EasternExtended Trading$5.01 +0.23 (+4.70%) As of 07/18/2025 04:37 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.Soleno Therapeutics NASDAQ:SLNO$87.20 -0.44 (-0.50%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$87.16 -0.05 (-0.05%) As of 07/18/2025 04:32 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet, which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/14 - 07/18 Netflix Q2 2025 Earnings: What Investors Need to Know High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Snap-On: Snap Up This Strong Signal While It’s Still Cheap Why Abbott Laboratories Is a Q2 2025 Buy: Growth & Yield Why Pure Storage Is a Core Investment for the AI Era Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
